A recent study tested the effects of the immunotherapy drug pembrolizumab, also known as Keytruda, on patients with a common type of lung cancer.
最近的一项研究测试了免疫治疗药物派姆单抗（也称为 Keytruda）对常见类型肺癌患者的效果。
英语百科
Pembrolizumab
Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda) is a humanized antibody used in cancer immunotherapy. It targets the programmed cell death 1 (PD-1) receptor. The drug was initially used in treating metastatic melanoma.